Dextrometorfano [Inn-Spanish]
Brand names,
Dextrometorfano [Inn-Spanish]
Analogs
Dextrometorfano [Inn-Spanish]
Brand Names Mixture
Dextrometorfano [Inn-Spanish]
Chemical_Formula
C18H25NO
Dextrometorfano [Inn-Spanish]
RX_link
No information avaliable
Dextrometorfano [Inn-Spanish]
fda sheet
Dextrometorfano [Inn-Spanish]
msds (material safety sheet)
Dextrometorfano [Inn-Spanish]
Synthesis Reference
No information avaliable
Dextrometorfano [Inn-Spanish]
Molecular Weight
271.397 g/mol
Dextrometorfano [Inn-Spanish]
Melting Point
No information avaliable
Dextrometorfano [Inn-Spanish]
H2O Solubility
74.7 mg/L
Dextrometorfano [Inn-Spanish]
State
Solid
Dextrometorfano [Inn-Spanish]
LogP
4.323
Dextrometorfano [Inn-Spanish]
Dosage Forms
Capsule; Liquid; Lozenge; Syrup; Tablet
Dextrometorfano [Inn-Spanish]
Indication
For treatment and relief of dry cough.
Dextrometorfano [Inn-Spanish]
Pharmacology
Dextromethorphan suppresses the cough reflex by a direct action on the cough center in the medulla of the brain. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
Dextrometorfano [Inn-Spanish]
Absorption
Rapidly absorbed from the gastrointestinal tract.
Dextrometorfano [Inn-Spanish]
side effects and Toxicity
No information avaliable
Dextrometorfano [Inn-Spanish]
Patient Information
No information avaliable
Dextrometorfano [Inn-Spanish]
Organisms Affected
Humans and other mammals